Aggressive Surgical Approach to the Management of Neuroendocrine Tumors: A Report of 1,000 Surgical Cytoreductions by a Single Institution
- 1 April 2017
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of the American College of Surgeons
- Vol. 224 (4), 434-447
- https://doi.org/10.1016/j.jamcollsurg.2016.12.032
Abstract
Surgical cytoreduction in NET patients has low morbidity and mortality rates and results in prolonged survival. We believe that surgical cytoreduction should play a major role in the care of patients with NETs.Keywords
This publication has 30 references indexed in Scilit:
- Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE)Annals Of Oncology, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Small Bowel Cancer in the United StatesAnnals of Surgery, 2009
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survivalSurgery, 2006
- Surgical Treatment of Advanced-Stage Carcinoid TumorsAnnals of Surgery, 2005
- Neuroendocrine Hepatic MetastasesAnnals of Surgery, 2005
- Surgical treatment of neuroendocrine metastases to the liver: : a plea for resection to increase survivalJournal of the American College of Surgeons, 2003
- Hepatic neuroendocrine metastases: does intervention alter outcomes?Journal of the American College of Surgeons, 2000
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958